Skip to main content

Table 2 Details of the chemotherapy schedule and doses used for stage T3-4 N0 nasopharyngeal carcinoma patients.

From: Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system

Mode of treatment Number of patients %
RT alone 6 17.6
CCRT 7 20.5
NAC + RT 2 5.9
NAC + CCRT 16 47.1
NAC + CCRT + ADC 3 8.8
  1. CCRT, concomitant chemo-radiotherapy (cisplatin, 80 mg/m2 on day 1, 22 and 43 or 40 mg/m2 weekly); NAC, neoadjuvant chemotherapy (cisplatin, 80 mg/m2 day 1; 5-flourouracil, 800 mg/m2 days 1-5); RT, radiotherapy; ADC, adjuvant chemotherapy (cisplatin, 80 mg/m2 day 1; 5-flourouracil, 800 mg/m2 days 1-5).